Skip to main content

Table 1 Prevalence of hybrid capture 2 positive-women by age and recruitment centre

From: Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial

HPV+/Tested women (prevalence%)
Age groups 25-29 30-34 35-39 40-44 45-49 50-54 55-60 Total
Verona 69/587 (11.8%) 104/736 (14.1%) 62/632 (9.8%) 43/533 (8.1%) 28/322 (8.7%) 37/476 (7.8%) 20/449 (4.5%) 363/3735 (9.7%)
Padua 142/994 (14.3%) 124/1013 (12.2%) 134/948 (14.1%) 59/799 (7.4%) 33/551 (6.0%) 10/262 (3.8%) 13/723 (1.8%) 515/5290 (9.7%)
Ravenna 65/340 (19.1%) 67/521 (12.9%) 68/591 (11.5%) 43/628 (6.8%) 36/582 (6.2%) 31/548 (5.7%) 38/541 (7.0%) 348/3751 (9.3%)
Florence 150/926 (16.2%) 141/1045 (13.5%) 138/1277 (10.8%) 103/1306 (7.9%) 90/1227 (7.3%) 58/1204 (4.8%) 48/1129 (4.3%) 728/8114 (9.0%)
Imola 58/325 (17.8%) 50/415 (12.0%) 48/528 (9.1%) 41/510 (8.0%) 28/373 (7.5%) 17/406 (4.2%) 17/357 (4.8%) 259/2914 (8.9%)
Turin 274/1761 (15.6%) 252/1909 (13.2%) 166/2219 (7.5%) 132/2142 (6.2%) 99/1860 (5.3%) 99/1904 (5.2%) 84/2015 (4.2%) 1106/13810 (8.0%)
Bologna 28/137 (20.4%) 29/262 (11.1%) 43/418 (10.3%) 35/480 (7.3%) 24/413 (5.8%) 22/432 (5.1%) 16/428 (3.7%) 197/2570 (7.7%)
Viterbo 71/507 (14.0%) 35/390 (9.0%) 36/501 (7.2%) 27/460 (5.9%) 34/440 (7.7%) 17/376 (4.5%) 14/415 (3.4%) 234/3089 (7.6%)
Trento 43/400 (10.8%) 41/572 (7.2%) 39/634 (6.2%) 34/632 (5.4%) 22/501 (4.4%) 16/459 (3.5%) 12/429 (2.8%) 207/3627 (5.7%)
Total 900/5977 (15.1%) 843/6863 (12.3%) 734/7748 (9.5%) 517/7490 (6.9%) 394/6269 (6.3%) 307/6067 (5.1%) 262/6486 (4.0%) 3957/46900 (8.4%)